Juan L. Vivero-Escoto, Ph.D. - Publications

2009 Chemistry Iowa State University, Ames, IA, United States 
Nanoscience, Pharmaceutical Chemistry, Biochemistry

14 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Ceja-Fdez A, López-Luke T, Oliva J, Vivero-Escoto J, Gonzalez-Yebra AL, Rojas RA, Martínez-Pérez A, de la Rosa E. Labeling of HeLa cells using ZrO2:Yb(3+)-Er(3+) nanoparticles with upconversion emission. Journal of Biomedical Optics. 20: 046006. PMID 25879389 DOI: 10.1117/1.JBO.20.4.046006  0.92
2015 Rocca JD, Werner ME, Kramer SA, Huxford-Phillips RC, Sukumar R, Cummings ND, Vivero-Escoto JL, Wang AZ, Lin W. Polysilsesquioxane nanoparticles for triggered release of cisplatin and effective cancer chemoradiotherapy. Nanomedicine : Nanotechnology, Biology, and Medicine. 11: 31-8. PMID 25038495 DOI: 10.1016/j.nano.2014.07.004  0.92
2015 Cepeda-Pérez EI, López-Luke T, Pérez-Mayen L, Hidalgo A, De La Rosa E, Torres-Castro A, Ceja-Fdez A, Vivero-Escoto J, Gonzalez-Yebra AL. Wet chemical synthesis of quantum dots for medical applications Progress in Biomedical Optics and Imaging - Proceedings of Spie. 9537. DOI: 10.1117/12.2183183  0.92
2011 Vivero-Escoto JL, Taylor-Pashow KM, Huxford RC, Della Rocca J, Okoruwa C, An H, Lin W, Lin W. Multifunctional mesoporous silica nanospheres with cleavable Gd(III) chelates as MRI contrast agents: synthesis, characterization, target-specificity, and renal clearance. Small (Weinheim An Der Bergstrasse, Germany). 7: 3519-28. PMID 22069305 DOI: 10.1002/smll.201100521  0.92
2011 Tsai CH, Vivero-Escoto JL, Slowing II, Fang IJ, Trewyn BG, Lin VS. Surfactant-assisted controlled release of hydrophobic drugs using anionic surfactant templated mesoporous silica nanoparticles. Biomaterials. 32: 6234-44. PMID 21684000 DOI: 10.1016/j.biomaterials.2011.04.077  0.92
2011 Slowing II, Vivero-Escoto JL, Zhao Y, Kandel K, Peeraphatdit C, Trewyn BG, Lin VS. Exocytosis of mesoporous silica nanoparticles from mammalian cells: from asymmetric cell-to-cell transfer to protein harvesting. Small (Weinheim An Der Bergstrasse, Germany). 7: 1526-32. PMID 21520497 DOI: 10.1002/smll.201002077  0.92
2010 Zhao Y, Vivero-Escoto JL, Slowing II, Trewyn BG, Lin VS. Capped mesoporous silica nanoparticles as stimuli-responsive controlled release systems for intracellular drug/gene delivery. Expert Opinion On Drug Delivery. 7: 1013-29. PMID 20716017 DOI: 10.1517/17425247.2010.498816  0.92
2010 Vivero-Escoto JL, Slowing II, Trewyn BG, Lin VS. Mesoporous silica nanoparticles for intracellular controlled drug delivery. Small (Weinheim An Der Bergstrasse, Germany). 6: 1952-67. PMID 20690133 DOI: 10.1002/smll.200901789  0.92
2010 Vivero-Escoto JL, Slowing II, Lin VS. Tuning the cellular uptake and cytotoxicity properties of oligonucleotide intercalator-functionalized mesoporous silica nanoparticles with human cervical cancer cells HeLa. Biomaterials. 31: 1325-33. PMID 19932923 DOI: 10.1016/j.biomaterials.2009.11.009  0.92
2010 Slowing II, Vivero-Escoto JL, Trewyn BG, Lin VSY. Mesoporous silica nanoparticles: Structural design and applications Journal of Materials Chemistry. 20: 7924-7937. DOI: 10.1039/c0jm00554a  0.92
2009 Mortera R, Vivero-Escoto J, Slowing II, Garrone E, Onida B, Lin VS. Cell-induced intracellular controlled release of membrane impermeable cysteine from a mesoporous silica nanoparticle-based drug delivery system. Chemical Communications (Cambridge, England). 3219-21. PMID 19587919 DOI: 10.1039/b900559e  0.92
2009 Vivero-Escoto JL, Slowing II, Wu CW, Lin VS. Photoinduced intracellular controlled release drug delivery in human cells by gold-capped mesoporous silica nanosphere. Journal of the American Chemical Society. 131: 3462-3. PMID 19275256 DOI: 10.1021/ja900025f  0.92
2009 Slowing II, Wu CW, Vivero-Escoto JL, Lin VS. Mesoporous silica nanoparticles for reducing hemolytic activity towards mammalian red blood cells. Small (Weinheim An Der Bergstrasse, Germany). 5: 57-62. PMID 19051185 DOI: 10.1002/smll.200800926  0.92
2008 Slowing II, Vivero-Escoto JL, Wu CW, Lin VS. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Advanced Drug Delivery Reviews. 60: 1278-88. PMID 18514969 DOI: 10.1016/j.addr.2008.03.012  0.92
Show low-probability matches.